keywords: stroke recovery myelin
When a stroke occurs, the standard account of what has been lost and what might be recovered is framed almost entirely in terms of neurons. The infarct kills neurons. The surviving neurons attempt to compensate. Rehabilitation trains new neural pathways. Recovery, on this account, is not reconstruction. It is reconnection. The difference matters. A stroke that severs a myelinated pathway is not a wildfire that destroys both the road and the town it leads to. It is a sinkhole that closes the road while the town remains intact. The destination, the accumulated white matter that constitutes the ability, is still there. The work of recovery is to find a new route to it.
The Myelin Mind thesis suggests this framing is incomplete in a way that matters clinically. What stroke destroys is not just neurons. It destroys myelinated pathways. And the distinction between destroying a pathway and destroying an ability is not semantic. It is the difference between a road being closed and the destination ceasing to exist.
What the stroke actually damages
A vascular stroke, whether ischaemic or haemorrhagic, kills tissue in the affected territory through oxygen deprivation or mechanical disruption. Both grey matter and white matter die within the infarct core. But surrounding the core is the penumbra: tissue that is damaged but not destroyed, where neurons are stressed and myelinated pathways are compromised but where recovery is possible.
The question the Myelin Mind thesis asks is not which neurons survived but which myelinated structures survived. The accumulated white matter of the affected territory, the biological record of everything the person knew how to do with the damaged pathways, does not simply vanish with the infarct. In the penumbra and in adjacent tissue, it persists. The ability to speak, to move a limb, to recognise a face: these are inscribed in myelinated structure. The stroke has not erased them. It has severed the pathways through which they were expressed.
Recovery, on this account, is not reconstruction. It is reconnection.
The same problem as the spinal cord
The challenge of stroke recovery shares a deep structure with the challenge of spinal cord repair. In both cases, axons attempt to sprout and form new connections after injury. In both cases, they encounter myelin debris at the injury site. And in both cases, the inhibitory proteins associated with myelin, Nogo-A, MAG and OMgp, trigger the collapse of the growth cone, halting regeneration before it can establish new pathways.
This is not a design flaw. As the spinal cord argument established, it is the white matter defending its accumulated structure against the intrusion of rogue axons. In an intact nervous system, an unmyelinated axon sprouting into territory already structured by decades of myelination would disrupt the very architecture that constitutes ability. The inhibitory response is the immune system of white matter.
After stroke, however, this protective response becomes an obstacle. The axons attempting to reroute around the infarct are not rogue intruders. They are the surviving pathways of the damaged system, attempting to find new routes to the same destinations. The inhibitory proteins that stop them are doing their job. But their job, in this context, is preventing recovery.
The first stage of any effective stroke repair protocol, on this account, must be the suppression of myelin inhibitory proteins in the peri-infarct zone. Not because myelin inhibition is a design flaw to be overcome, but because the context has changed. The white matter debris at the injury site is no longer defending intact structure. It is blocking the rerouting that recovery requires. Agents that suppress Nogo-A receptor signalling, chondroitinase ABC to clear inhibitory proteoglycans, and related approaches currently under investigation are, on the Myelin Mind account, doing precisely the right thing for precisely the right reason.
The astrocyte as scaffold
Once the inhibitory block is cleared, axons can sprout. But sprouting axons do not grow in a vacuum. They require guidance, chemical gradients and cellular substrates that direct their growth toward appropriate targets. In the peripheral nervous system this guidance is provided by Schwann cells. In the central nervous system, astrocytes play the analogous role.
The astrocyte’s first function in stroke recovery is scaffolding. Rather than forming the dense, inhibitory glial scar that develops after acute injury, astrocyte precursors in a permissive environment can provide a bed for axon regrowth, secreting neurotrophic factors and creating the extracellular conditions that allow the sprouting axon to navigate toward its target. This is why the timing and character of the inflammatory response after stroke matters so much: the astrocyte response in the acute phase can either facilitate or foreclose the rerouting that recovery depends on.
But the astrocyte’s role does not end with scaffolding.
The lactate signal
Once the rerouted axons are in place and neural activity begins to flow through the new pathways, something remarkable happens. Intense neural activity triggers astrocytes to shuttle lactate to the active axons and the cells surrounding them. This is a well-established feature of neural metabolism: astrocytes take up glucose, convert it to lactate, and supply it to neurons under conditions of high demand.
What is less widely appreciated is what the lactate signal does next.
Lactate is not merely fuel. It is the primary building block of myelin synthesis. The fatty acids that compose the myelin sheath are synthesised from lactate. When astrocytes flood the peri-axonal environment with lactate in response to intense neural activity, they are simultaneously fuelling the active axon and providing the raw material for the oligodendrocytes that will myelinate it.
Lactate is also a direct signal for oligodendrocyte recruitment. Oligodendrocyte precursor cells respond to elevated lactate concentrations in the extracellular environment by differentiating and migrating toward the active pathway. The intense neural activity that drives astrocyte lactate shuttling is thus the signal that calls in the myelinating cells. The astrocyte does double duty: first as the scaffold that guides the sprouting axon, then as the metabolic intermediary that recruits the oligodendrocyte and supplies it with the material it needs to build the sheath.
The three-stage repair process, clearing inhibitory proteins, routing axons through an astrocyte scaffold, and recruiting oligodendrocytes to remyelinate, is not three separate interventions. It is one continuous biological process, each stage triggering the next.
Why rehabilitation works
This account of stroke recovery has a direct implication for rehabilitation that is both clarifying and clinically significant.
The intensive, repetitive practice of the lost function, whether speech, movement or cognition, that neurologists prescribe after stroke has long been known to be more effective than passive recovery or general exercise. The standard explanation is motor learning: repetitive practice drives synaptic plasticity, strengthening the connections that support the recovered function.
The Myelin Mind account suggests something more specific is happening. The intense, repetitive neural activity of rehabilitation is doing exactly what the lactate signalling pathway requires. It is driving the astrocyte lactate shuttle. It is creating the metabolic signal that recruits oligodendrocytes to the rerouted pathways. It is providing the building blocks for myelin synthesis. Rehabilitation is not just retraining neurons. It is remyelinating pathways.
This reframing has practical consequences. It suggests that the intensity and specificity of rehabilitation matters not just for synaptic reasons but for myelination reasons. Low-intensity, non-specific activity will not drive the lactate signal with sufficient force to recruit oligodendrocytes efficiently. The practice must be intense and it must be specific to the lost function, because oligodendrocyte recruitment follows the active pathways, and the pathways that are active are the ones being practised.
It also suggests a therapeutic window that has not been fully exploited. If oligodendrocyte recruitment is the final stage of recovery, then agents that support oligodendrocyte differentiation and survival, combined with intensive rehabilitation, should produce better outcomes than rehabilitation alone. The axon rerouting creates the pathway. The rehabilitation drives the lactate signal. The oligodendrocyte completes the repair. All three are necessary. Current rehabilitation protocols address only the middle stage.
The ability is still there
The deepest implication of this account is the one that is hardest to measure but most important to understand.
The standard account of severe stroke implies that the lost function is gone, that the neurons that supported it are dead and the ability they encoded is destroyed. On this account, recovery is always partial, always compensatory, always a matter of learning to do something different rather than restoring what was lost.
The Myelin Mind account suggests otherwise. The myelinated structure that constitutes the ability, the decades of accumulated white matter that encode the patient’s speech, movement and cognition, is not destroyed by the infarct. It persists in the surviving tissue. What the stroke has severed is the pathway through which that structure is expressed. Recovery is the restoration of that pathway, through axon rerouting and remyelination, not the creation of a new one.
This is not a counsel of false optimism. Severe strokes destroy white matter as well as grey, and the most severely affected patients face genuine structural loss. But for the large population of stroke survivors with penumbral damage and preserved white matter in adjacent regions, the implication is significant.
The ability is still there. The task of recovery is to reconnect it.
The lactate signal is the body’s own mechanism for doing exactly that. Rehabilitation, understood through the Myelin Mind lens, is not retraining a damaged brain. It is activating the biological process that rebuilds the road to an intact destination.
Jack Parry is a philosopher and biomedical animator at Swinburne University of Technology. He is the author of The Myelin Mind: The Genesis of Meaning.